International Stem Cell (ISCO) Operating Interest Expenses (2013 - 2016)
International Stem Cell's (ISCO) quarterly Operating Interest Expenses came in at $59000.0 in Q2 2016, down 93.21% quarter-over-quarter from $869000.0 in Q1 2016.
Powered by 
Analysis
International Stem Cell (ISCO) Operating Interest Expenses (2013 - 2016) Analysis & Trends
International Stem Cell (ISCO) has reported Operating Interest Expenses for 2 consecutive years, with $59000.0 the latest figure, recorded in Q2 2016.
- On a quarterly basis, Operating Interest Expenses changed N/A year-over-year to $59000.0 in Q2 2016; TTM through Dec 2016 was $928000.0, a N/A change from a year earlier, with the FY2016 full-year figure at $928000.0, changed N/A from the prior year.
- Operating Interest Expenses was $59000.0 for Q2 2016 at International Stem Cell, down from $869000.0 in the prior quarter.
- Over five years, Operating Interest Expenses peaked at $869000.0 in Q1 2016 and troughed at $59000.0 in Q2 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Interest Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | - |
| 10 | International Stem Cell | 2.84 Mn | 1.75 Mn | 1.46 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2016 | 59,000.00 |
| Mar 31, 2016 | 869,000.00 |
| Sep 30, 2013 | 738,000.00 |